Navigation Links
One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
Date:9/21/2007

?unode=3B96906B-C026-2FD3-

87B73F80BC22682A. Accessed June 14, 2007.

5 All About Diabetes." American Diabetes Association. Available at:

http://www.diabetes.org/about-diabetes.jsp. Accessed June 14, 2007

6 Direct and Indirect Costs of Diabetes in the United States." American

Diabetes Association. Available at: http://www.diabetes.org/diabetes-

statistics/cost-of-diabetes-in-us.jsp. Accessed June 14, 2007.

7 Saydah SH, Fradkin J, Cowie CC. "Poor control of risk factors for

vascular disease among adults with previously diagnosed diabetes."

JAMA. 2004: 291(3), 335-342.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040122/LILLYAMYLINLOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Amber Pharmacy announced today that it received accreditation by ... specialized pharmacy services. For nearly 15 years, Amber Pharmacy ... meet the unique needs of specialized conditions. Amber Pharmacy ... transplant programs. They work with over 170 transplant programs ...
(Date:12/4/2009)... Imaging, LLC, an independent provider of CT, MRI ... and healthcare providers, is excited to announce it ... Health Care, a nationally-recognized, prestigious gold seal of ... Shared Imaging accreditation is system-wide for its mobile ...
(Date:12/4/2009)... often stored in tin cans and car trunks ... RetireSafe urged the Senate to defeat the Dorgan Importation plan ... Dorgan,s importation amendment is poised to open our borders, allowing ... health to be endangered. We could soon be getting ...
Breaking Medicine Technology:Amber Pharmacy Earns Accreditation From ACHC 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2Giant Eagle Pharmacy to Offer Customers in Ohio a Dose of Economic Relief Through Free Antibiotics Program 56196 1Giant Eagle Pharmacy to Offer Customers in Ohio a Dose of Economic Relief Through Free Antibiotics Program 56196 2Giant Eagle Pharmacy to Offer Customers in Ohio a Dose of Economic Relief Through Free Antibiotics Program 56196 3Is it Exam Time for Students Already 3F 56191 1Is it Exam Time for Students Already 3F 56191 2Is it Exam Time for Students Already 3F 56191 3Is it Exam Time for Students Already 3F 56191 4Is it Exam Time for Students Already 3F 56191 5Reportlinker Adds The Market for Minimally Invasive Medical Devices Report 56187 1Reportlinker Adds The Market for Minimally Invasive Medical Devices Report 56187 2Reportlinker Adds The Market for Minimally Invasive Medical Devices Report 56187 3
... Switzerland, April 30 An innovative treatment for,infections ... has received,orphan drug designation in the US. Axentis ... designation has been granted to its,product candidate Fluidosomes-tobramycin, ... II clinical trials. The company has now been ...
... April 30 Arrayit Corporation (OTC Bulletin Board: ARYC), ... prevention, treatment and cure, announced today that it is ... swine flu virus. The Arrayit test will allow researchers ... in infected patients and livestock and to distinguish the ...
Other Medicine Technology:Cystic Fibrosis - Orphan Drug Designation for Innovative Treatment Against Lung Infections by Axentis Pharma AG 2Cystic Fibrosis - Orphan Drug Designation for Innovative Treatment Against Lung Infections by Axentis Pharma AG 3Arrayit to Mass Produce Rapid H1N1 Swine Flu Test Chip 2Arrayit to Mass Produce Rapid H1N1 Swine Flu Test Chip 3
(Date:12/6/2009)... Dec. 6 Blood clotting, or coagulation, ... when a blood vessel is injured. Sometimes, however, ... an obvious injury or do not dissolve naturally, ... today at the 51st Annual Meeting of the ... of using the anticoagulants aspirin and heparin with ...
(Date:12/6/2009)... in cooperation with the Greater VA Healthcare System in West Los ... is expected to soar to more than 5,000 veterans, active military ... ... December 6, 2009 -- Volunteer organizations and members of the community, ... Angeles, will once again create a holiday party. This year,s attendance ...
(Date:12/5/2009)... 5 There have been significant scientific advances in ... to gain a better understanding of how certain diseases ... provide patients with the best care. Research presented today ... of Hematology explores optimal induction therapies for managing multiple ...
(Date:12/5/2009)... Is Most Challenging-- ,, PHILADELPHIA and NEW ... genes, dubbed partner genes, that fuse with another gene ... By more accurately defining specific partner genes, researchers expect ... treatments. ,, Oncologists also aim to use this ...
(Date:12/5/2009)... wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay ... 40th birthday without ever tying the knot, since research has ... folks. And, um, isn,t there something wrong with those who ... new study looking at psychological measures shows that never-married people ...
Breaking Medicine News(10 mins):Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3
... patients undergoing total abdominal hysterectomy and laparoscopically assisted ... instead. Despite the advantages of lower morbidity // ... by the vaginal route, although there is a ... complex and gynecologists need to be familiar with ...
... sleep apnea share some common symptoms, due to which physicians ... sleep apnea (OSA) occurs when the tongue or throat muscles ... This can happen more than 50 times an hour during ... long as 60 seconds. The problem is twice as common ...
... High Commission organized a seminar to explore the possibility ... ventures in services and manufacturing. They invited the // ... lead the discussion with Indian partners in Chennai on ... Hawkins and the group had discussion with healthcare providers ...
... to have a higher risk of developing breast cancer due ... a new research has concluded. //, ,Hodgkin's is a ... system organs. Researchers found that women had a 40 percent ... lymphoma. Dr Lois B. Travis, from the National Cancer Institute ...
... transfer of microorganisms and biological materials from the US ... But slow implementation of the country’s broader biotech // ... hub of contract research and clinical trials, may threaten ... ,Discussions in mid-June between acting US deputy secretary of ...
... National Hospital, Oslo and other collaborating Universities from many ... 20 years in 900 adults has found that // ... risk of oral cancer in smoking individuals by at ... of developing cardiovascular deaths, the study has found that ...
Other Medicine News:Health News:Reversibility of symptoms of depression using CPAP in patients with obstructive sleep apnea 2Health News:Biologicals Transfer Proposal between US and Indian Biotechnology 2Health News:NSAIDS, Reduces The Risk Of Oral Cancer But Causes Heart Attacks 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: